Página 3 - Melhores Cancro do pulmão estádio 4 médicos - TOP-81 médicos

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Especialista em viroterapia – uma abordagem de ponta para o tratamento do cancro do pulmão com mais de 30 anos de experiência.

• Licenciar-se no Instituto Médico de Riga
• Realizar internato em Medicina Interna
• Chefiar o Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins

A Professora Gül Alco é especialista em rádio-oncologia para cancro do pulmão no Hospital Medipol Acibadem District.

• Mais de 20 anos de experiência em rádio-oncologia
• Professora na Universidade Istanbul Medipol
• Formação na Universidade de Istambul e na Universidade Kadir Has
• Trabalhar no Hospital Şişli Florence Nightingale

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Especialista em oncologia cirúrgica torácica, incluindo cirurgias avançadas de cancro do pulmão no Medical Park Göztepe Hospital Complex. Oferece VATS (cirurgia toracoscópica assistida por vídeo) para procedimentos precisos e minimamente invasivos.

• Vasta experiência em cirurgia de cancro do pulmão e tratamentos de doenças pleurais
• Formado na Universidade de Paris-Sud e no Hospital Marie-Lannelongue, França
• Membro da Sociedade Europeia de Cirurgiões Torácicos
• Publicação de inúmeros artigos sobre temas de cirurgia torácica

O Dr. Semenisity é especialista em oncologia médica e radioterapia no Rambam Medical Center.

• Especialista em tratamentos avançados contra o cancro do pulmão
• Focar em planos de terapia personalizados
• Trabalhar com uma equipa multidisciplinar

O Dr. Meirovitz traz décadas de experiência em oncologia para o Hadassah Medical Center, um dos principais hospitais de Israel.

• Graduado pela Faculdade de Medicina da Universidade Technion em 1990
• Especialização em tratamentos de câncer de pulmão em estágio avançado
• Prática no Hadassah – uma instituição médica de alto nível

A Professora Tamar Jablonski-Perec chefia o Instituto de Oncologia do Hadassah Medical Center, com formação do Sloan-Kettering Cancer Center.

• Mais de 25 anos liderando programas de oncologia
• Especialização no tratamento avançado de cancro da mama e do pulmão
• Membro de comunidades internacionais de investigação do cancro
• Professora no departamento de oncologia da Universidade Hebraica
• Premiada com a prestigiada bolsa da Hadassah Medical School

A Dra. Zalmanova é especialista em radioterapia para câncer de pulmão no Assuta Medical Center.

• Radioterapeuta com foco no tratamento do câncer de pulmão
• Trabalhando no Assuta Medical Center, uma instituição líder em cuidados oncológicos
• Dedicação a planos de tratamento personalizados para cada paciente

Especializado em cirurgia torácica minimamente invasiva para cancro do pulmão – o Dr. Adnansayar realiza procedimentos toracoscópicos e robóticos no Liv Hospital Ulus.

• Focar em cancros do pulmão e cirurgia da traqueia
• Especialista em transplante pulmonar e cirurgia de doenças pleurais
• Também experiente em cirurgia torácica pediátrica
• Licenciado pela Faculdade de Medicina da Universidade de Istambul

Autor de mais de 30 artigos científicos sobre o tratamento de malignidades – o Dr. Derin é um oncologista de renome no Liv Hospital Ulus.

• Especializar-se em cancros gastrointestinais e de pulmão
• Membro da Sociedade Europeia de Oncologia Médica (ESMO)
• Professor associado com vasta experiência académica
• Licenciar-se pela Faculdade de Medicina da Universidade de Istambul

A Dra. Ece formou-se no MD Anderson Cancer Center – um dos melhores hospitais de oncologia do mundo – especializando-se em cancro do pulmão. Ela traz essa experiência para o Liv Hospital Ulus.

• Bolsa de pós-doutoramento em cancro do pulmão no MD Anderson
• Formada em broncoscopia intervencionista na Johns Hopkins
• Membro da Direção Executiva da Sociedade Turca de Cancro do Pulmão
• Publicação de 48 artigos de investigação internacionais
• Membro (Fellow) do American College of Chest Physicians